Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 7.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2003 to 2007

Recipients with Pancreas After Kidney (PAK) Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 441 100.0% 1,023 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 6 1.4% 15 1.5%
OKT3 1 0.2% 3 0.3%
Thymoglobulin 259 58.7% 567 55.4%
Zenapax 9 2.0% 75 7.3%
Simulect 10 2.3% 74 7.2%
Campath 145 32.9% 95 9.3%
Rituximab     2 0.2%
No Induction Drug Reported 70 15.9% 235 23.0%


Source: OPTN/SRTR Data as of May 1, 2008.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.



PDF FormatRequires Adobe Acrobat Reader